Latest Pexa (ASX:PXA) News

AI infrastructure deals drove the week’s biggest technology share moves, led by X2M’s 350% surge and fresh data-centre contracts for DXN. Strong company results were mixed with investor reactions, as profitable growth lifted several stocks while losses, legal issues and weak outlooks punished others.

PEXA Group delivered a solid FY26 with 7% revenue growth and a return to profitability, while facing a regulatory pricing review that could reshape its future investment capacity.

Takeover bids sent EQT Holdings sharply higher, while Ovanti collapsed after leaving the buy now, pay later market. Strong results from lenders and fund managers were offset by steep falls in several stocks.

Investors also weighed dividends, buy-backs, cost cuts and regulatory risks across a busy week of company news.

PEXA has lodged a detailed response to IPART’s draft report on ELNO service fees, revealing FY26 transaction volumes and flagging a downturn in FY27 amid economic headwinds. The company backs its case with independent expert critiques and awaits regulatory outcomes.

Nanoveu led the week after live drone trials, while Gratifii slumped on deal changes and X2M dropped after a discounted capital raising. Across the tech board, buyers backed real revenue, cash receipts and contract wins, but punished dilution, legal noise and weak post-gap trading.

PEXA contested IPART’s regulatory approach to setting its Initial Asset Base during a public hearing, warning that the proposed valuation could jeopardise its financial sustainability and operational stability.

Dealmaking and capital moves drove the week in financials, while one regulatory shock hit hard. PEXA slumped, but Magellan, Euroz Hartleys and several smaller finance names rose on mergers, asset sales and balance-sheet updates.

PEXA faces a proposed 20% cut in regulated ELNO service fees, risking a $70 million revenue reduction over a year. The company urges a phased approach to mitigate business impact as IPART opens public consultation.

Gold explorers and small-cap tech names drove the biggest share price swings this week, while one healthcare stock sank after a deeply discounted funding move. Deals, drill hits and fresh financing dominated trading across the ASX.

Small-cap tech buyers chased AI, defence and digital infrastructure this week, while a few names gave back gains after reopening jumps. The biggest moves came from contract wins, fresh capital and clear signs that products are getting closer to real sales.

PEXA Group delivered a 7.3% rise in Australian property transaction volumes in 3Q26 and saw steady UK remortgage growth despite macroeconomic uncertainty. The company reaffirmed its FY26 guidance, aiming for NPAT at the top of its $15m-$25m range.

A brutal sell-off in PEXA swamped an otherwise upbeat week for small-cap tech, where contract wins and product launches did the heavy lifting. RocketBoots led the gainers as investors paid up for near-term rollout revenue, while Adveritas rallied on a big push into self-serve SME sales.